Results · Apr-Jun 2026
Torrent Pharmaceuticals Q1 FY27 results
Sales grew 55% to ₹4,921 crore from ₹3,178 crore in Apr-Jun 2025.
Operating profit grew 61% to ₹1,664 crore, an operating margin of 33.8% (up 1.3 points from a year ago).
Net profit grew 3% to ₹566 crore from ₹548 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +17%, net profit +55%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 4,921 | 3,178 | +55% |
| Operating profit (EBITDA) | 1,664 | 1,032 | +61% |
| Operating margin | 33.8% | 32.5% | +1.3 pts |
| Net profit | 566.0 | 548.0 | +3% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.